Cephalon Files Treanda For Chronic Lymphocytic Leukemia
This article was originally published in The Pink Sheet Daily
Executive Summary
Submission represents a milestone for Cephalon’s oncology program, firm says.
You may also be interested in...
Treanda Approved; Cephalon Ready With Tripled Salesforce To Launch In Chronic Lymphocytic Leukemia
Firm expects to ship product within 2-3 weeks, Cephalon tells “The Pink Sheet” DAILY.
Treanda Approved; Cephalon Ready With Tripled Salesforce To Launch In Chronic Lymphocytic Leukemia
Firm expects to ship product within 2-3 weeks, Cephalon tells “The Pink Sheet” DAILY.
Cephalon Files Treanda For NHL Indication
Chemotherapeutic has been granted a priority review for an earlier filing, for treatment of chronic lymphocytic leukemia.